MF
PNT

Magnetar Financial’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Magnetar Financial’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,514
Closed -$159 – 1571
2021
Q2 		$159 Buy
15,514
+2,519
+19% +$25.6K ﹤0.01% 1128
2021
Q1 		$137K Buy
+12,995
New +$176K ﹤0.01% 1000

Other funds holding PNT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Magnetar Financial's PNT Position: Q3 2021 in Review

Magnetar Financial sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2021, closing a stake of 15,514 shares — an estimated $159 sold.

Magnetar Financial first reported a position in PNT in Q1 2021 and held it in 2 quarters. The position peaked at $137K in Q1 2021. 34 funds tracked by Wall St. Rank hold PNT as of Q3 2021.

  • Magnetar Financial reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Magnetar Financial sold 15,514 POINT Biopharma Global Inc. Common Stock shares in Q3 2021, an estimated $159.
  • Magnetar Financial first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Magnetar Financial's POINT Biopharma Global Inc. Common Stock position peaked at $137K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2021.

Based on Magnetar Financial's 13F filing for Q3 2021, filed 12 Nov 2021.